Make An Appointment
+
Book Appointment Online with select physicians.
Request Appointment Online to schedule with one of our coordinators.
1.888.IUHEALTH for
Same-Day Primary Care Appointments.
If you are experiencing a medical emergency, please call 9-1-1.
triangle

Hematology/Oncology

IU Health is offering a one-year ASHP accredited PGY2 Residency in Hematology/Oncology at Indiana University Melvin and Bren Simon Cancer Center, a National Cancer Institute designated clinical cancer center. This residency program provides advanced training in the provision of comprehensive clinical services to patients with cancer. Areas of focus include hematologic malignancies, solid tumor oncology, bone marrow transplant, gynecologic oncology and pediatric oncology. Experience in clinical trials oversight, teaching of pharmacy students and residents, participation in physician faculty conferences, policy development and participation in multidisciplinary committees is provided. Objectives of this residency parallel those developed by ASHP for PGY2 Residency Training in Oncology Pharmacy Practice.

PGY2 Hematology/ Oncology Residency Handout
 

Overview

Indiana University Health’s ASHP-accredited PGY 2 Oncology Residency emphasizes the development of advanced knowledge and application of pharmacotherapeutics in the provision of multi-disciplinary, quality care in patients with cancer. The Residency cultivates the skills of practice management and education and the professional attitudes of self-evaluation, self-improvement, and accountability. The successful resident will demonstrate a desire to learn, a sincere interest in the profession, dedication to achieving all outcomes of the residency, and the clinical and professional skill set to practice at the level of an oncology pharmacy specialist.

The PGY2 residency in oncology pharmacy is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients with cancer and non-malignant hematologic disorders. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for individuals with cancer, assuming responsibility for pharmaceutical care. They will gain competence in the preparation and dispensing of anticancer medications in accordance with USP797 guidelines. The wealth of residency graduates’ knowledge of neoplastic diseases, cancer-related and cancer treatment-related disorders, and the participation on interdisciplinary teams involved with the treatment of individuals with cancer produces a pharmacist who successfully serves health care organizations as the ultimate resource for information about anticancer medications and for decision-making affecting the care of these patients. This includes leadership in formulary decision-making for cancer-related medications.

Exiting residents are trained to practice at the level of a board certified oncology pharmacy specialist.  Residency graduates are trained to assume responsibility for identifying and implementing opportunities to improve the medication-use system in oncology practice areas. Because of the prominent use of investigational drugs in the treatment of individuals with cancer, they also possess the skills to practice effectively in clinical environments participating in clinical research efforts.
Groomed for practice leadership, oncology pharmacy residency graduates can be expected to continue their pursuit of expertise in practice; to possess advanced skills to identify the pharmacotherapy and medication-use training needs of other health care professionals caring for individuals with cancer; to deliver effective training to those health care professionals; and to contribute to public health efforts for health improvement, wellness, and cancer screening and prevention.


Rotation Structure

Rotation options include, but are not limited to:

  • HSCT 1
  • HSCT 2
  • Inpatient Hematology 1
  • Inpatient Hematology 2
  • Inpatient Oncology 1
  • Inpatient Oncology 2
  • Ambulatory Oncology Clinic 1
  • Ambulatory Oncology Clinic 2
  • Ambulatory Infusion Center 1
  • Ambulatory Infusion Center 2
  • Community Hospital Oncology
  • Methodist Hematology/Oncology Ambulatory Clinic
  • Inpatient Pediatric Hematology/Oncology
  • Outpatient Pediatric Hematology/Oncology
  • Gynecologic Oncology
  • Infectious Diseases
  • Surgical Oncology/SICU
  • Research
  • Longitudinal Ambulatory Clinic
  • Longitudinal Service Component
  • Clinical Weekends

 

Residency Completion

Upon the completion of this residency, the oncology pharmacy resident will have experience in the following areas:

  • Prospective evaluation of chemotherapy orders and serving as an authoritative resource for the appropriateness of treatment regimen, dosing and supportive care measures.
  • Participation in daily medical staff rounds.
  • Moderation of patient group teaching conferences and individual patient counseling opportunities.
  • Protocol review opportunities through the Indiana University Simon Cancer Center Scientific Review Committee and Institution IRB.
  • Provision of drug information to health care professionals affiliated with Indiana University Simon Cancer Center and surrounding health care settings.
  • Preparation and publication of manuscripts suitable for publication in the peer-reviewed literature.
  • Teaching and precepting Purdue University and Butler University PharmD students and IU Health PGY1 residents in both didactic and experiential settings.
  • Active involvement in the management of drug use policy efforts at IU Health, including participation in Pharmacy and Therapeutics (P&T) Committee activities, formulary management and implementation of drug prescribing guidelines.
  • Rotations through various ambulatory hematology and oncology clinics.
  • Serve as a liaison between physician and nursing staff for pharmacy investigational drug services.

 

How to Apply

The qualified applicant must possess a Doctor of Pharmacy Degree from an accredited college of pharmacy and must be eligible for Indiana licensure. Completion of a prior ASHP accredited PGY1 residency is required. All offers are contingent upon a background check, reference check, and pre-placement health assessment, which includes a drug test. If selected for an on-site interview, a presentation and completion of clinical case will be required.

Deadline for PhORCAS Application: January 5
Application Requirements (Submitted via PhORCAS)

  • Letter of Intent
  • Current Curriculum Vitae
  • Three ASHP Recommendation Forms
  • Official College Transcripts

 

Contact Information

Patrick J. Kiel, PharmD, BCPS, BCOP
Clinical Pharmacy Specialist
Hematology and Stem Cell Transplant
Indiana University Simon Cancer Center
550 N. University Blvd
Room AOC 6201
Indianapolis, IN  46202
317.948.5324
pkiel@iuhealth.org